Express Scripts Holding Company Company Profile (NASDAQ:ESRX)

About Express Scripts Holding Company

Express Scripts Holding Company logoExpress Scripts, Inc. is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM). PBM segment’s services include retail network pharmacy management and retail drug card programs, home delivery services, specialty benefit services, patient care contact centers, benefit plan design and consultation, drug formulary management, compliance and therapy management programs, information reporting and analysis programs, rebate programs, and electronic claims processing and drug utilization review. EM segment’s services include distribution of pharmaceuticals and medical supplies to providers and clinics and healthcare account administration and implementation of consumer-directed healthcare solutions.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Health Care Plans
  • Sub-Industry: Health Care Services
  • Exchange: NASDAQ
  • Symbol: ESRX
  • CUSIP: 30219G10
Key Metrics:
  • Previous Close: $69.97
  • 50 Day Moving Average: $69.86
  • 200 Day Moving Average: $71.75
  • 52-Week Range: $64.46 - $80.02
  • Trailing P/E Ratio: 12.98
  • Foreward P/E Ratio: 9.18
  • P/E Growth: 0.78
  • Market Cap: $42.38B
  • Outstanding Shares: 605,719,000
  • Beta: 0.92
Profitability:
  • Net Margins: 2.70%
  • Return on Equity: 24.99%
  • Return on Assets: 7.67%
Debt:
  • Debt-to-Equity Ratio: 0.96%
  • Current Ratio: 0.70%
  • Quick Ratio: 0.59%
Additional Links:
Companies Related to Express Scripts Holding Company:

Analyst Ratings

Consensus Ratings for Express Scripts Holding Company (NASDAQ:ESRX) (?)
Ratings Breakdown: 2 Sell Ratings, 8 Hold Ratings, 6 Buy Ratings
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $77.08 (10.17% upside)

Analysts' Ratings History for Express Scripts Holding Company (NASDAQ:ESRX)
Show:
DateFirmActionRatingPrice TargetDetails
2/17/2017Jefferies Group LLCReiterated RatingBuyView Rating Details
2/16/2017Credit Suisse GroupReiterated RatingBuy$85.00View Rating Details
2/14/2017Oppenheimer Holdings, Inc.Reiterated RatingHoldView Rating Details
12/16/2016Leerink SwannReiterated RatingMarket PerformView Rating Details
12/16/2016Barclays PLCReiterated RatingOverweightView Rating Details
12/16/2016MizuhoReiterated RatingNeutral$76.00View Rating Details
12/1/2016Sanford C. BernsteinReiterated RatingUnderperform$59.00View Rating Details
11/3/2016Deutsche Bank AGUpgradeSell -> Hold$69.00 -> $70.00View Rating Details
6/20/2016Morgan StanleyDowngradeEqual Weight -> Underweight$67.00 -> $70.00View Rating Details
6/15/2016Cowen and CompanyReiterated RatingPositive$83.00View Rating Details
6/7/2016Bank of America CorpReiterated RatingNeutral$82.00View Rating Details
6/1/2016WedbushReiterated RatingNeutralView Rating Details
5/24/2016Citigroup Inc.Reiterated RatingBuyView Rating Details
4/27/2016FBR & CoLower Price TargetMkt Perform$90.00 -> $75.00View Rating Details
4/17/2016ArgusReiterated RatingHoldView Rating Details
3/21/2016Evercore ISILower Price Target$74.00 -> $70.00View Rating Details
3/18/2016William BlairReiterated RatingBuyView Rating Details
2/18/2016Goldman Sachs Group, Inc. (The)Lower Price TargetNeutral$82.00 -> $74.00View Rating Details
2/17/2016Maxim GroupReiterated RatingBuy$109.00 -> $95.00View Rating Details
2/17/2016Robert W. BairdLower Price TargetNeutral$85.00 -> $80.00View Rating Details
12/23/2015BMO Capital MarketsBoost Price TargetMarket Perform$94.00View Rating Details
11/29/2015J P Morgan Chase & CoReiterated RatingBuy$105.00View Rating Details
7/30/2015Royal Bank Of CanadaBoost Price TargetOutperform$87.00 -> $96.00View Rating Details
6/18/2015StephensInitiated CoverageMarket PerformView Rating Details
6/1/2015Raymond James Financial, Inc.DowngradeOutperform -> Market PerformView Rating Details
(Data available from 2/20/2015 forward)

Earnings

Earnings History for Express Scripts Holding Company (NASDAQ:ESRX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/24/2017        
2/14/2017Q4 2016$1.87$1.88$26.31 billion$24.90 billionViewListenView Earnings Details
10/25/2016Q3$1.74$1.74$25.48 billion$25.41 billionViewListenView Earnings Details
7/25/2016Q216$1.57$1.57$25.42 billion$25.20 billionViewListenView Earnings Details
4/25/2016Q1$1.22$1.22$25.20 billion$24.80 billionViewListenView Earnings Details
2/16/2016Q4$1.56$1.56$26.58 billion$26.18 billionViewListenView Earnings Details
10/27/2015Q315$1.44$1.45$26.38 million$25.22 millionViewListenView Earnings Details
7/28/2015Q215$1.40$1.44$26.13 billion$25.45 billionViewListenView Earnings Details
4/28/2015Q115$1.10$1.10$24.34 billion$24.90 billionViewListenView Earnings Details
2/23/2015Q414$1.38$1.39$25.68 billion$26.31 billionViewListenView Earnings Details
10/28/2014Q314$1.29$1.29$24.93 billion$25.78 billionViewListenView Earnings Details
7/29/2014Q214$1.22$1.23$24.42 billion$25.11 billionViewListenView Earnings Details
4/29/2014Q114$1.01$0.99$23.81 billion$23.69 billionViewListenView Earnings Details
2/20/2014Q413$1.12$1.12$25.49 billion$25.78 billionViewN/AView Earnings Details
10/25/2013Q313$1.08$1.08$25.01 billion$25.92 billionViewListenView Earnings Details
7/29/2013Q2 2013$1.10$1.12$25.51 billion$26.40 billionViewListenView Earnings Details
4/29/2013Q1 2013$0.97$0.99$25.55 billion$26.06 billionViewListenView Earnings Details
2/18/2013Q4 2012$1.04$1.05$27.24 billion$27.41 billionViewListenView Earnings Details
11/5/2012Q312$0.99$1.02$27.48 billion$27.00 billionViewN/AView Earnings Details
8/7/2012$0.82$0.88ViewN/AView Earnings Details
5/10/2012$0.77$0.73ViewN/AView Earnings Details
2/22/2012$0.85$0.82ViewN/AView Earnings Details
10/25/2011$0.77$0.79ViewN/AView Earnings Details
7/21/2011$0.69$0.71ViewN/AView Earnings Details
4/26/2011$0.69$0.66ViewN/AView Earnings Details
2/16/2011$0.70$0.71ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Express Scripts Holding Company (NASDAQ:ESRX)
Current Year EPS Consensus Estimate: $6.93 EPS
Next Year EPS Consensus Estimate: $7.62 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 201613$1.20$1.36$1.24
Q2 201610$1.52$1.59$1.55
Q3 20166$1.74$1.74$1.74
Q4 20166$1.86$1.87$1.87
Q1 20175$1.31$1.34$1.32
Q2 20175$1.67$1.73$1.69
Q3 20175$1.87$1.91$1.88
Q4 20175$2.01$2.11$2.05
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Express Scripts Holding Company (NASDAQ:ESRX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Express Scripts Holding Company (NASDAQ:ESRX)
Insider Ownership Percentage: 0.54%
Institutional Ownership Percentage: 85.36%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/3/2017Everett NevilleVPSell1,123$69.41$77,947.43View SEC Filing  
9/14/2016Woodrow A Myers JrDirectorSell12,036$70.40$847,334.40View SEC Filing  
9/12/2016Christopher A McginnisVPSell1,785$70.77$126,324.45View SEC Filing  
5/10/2016Everett NevilleVPSell800$74.11$59,288.00View SEC Filing  
4/29/2016Mahon Thomas P MacDirectorSell5,482$73.93$405,284.26View SEC Filing  
3/10/2016Christopher A McginnisVPSell579$68.56$39,696.24View SEC Filing  
3/7/2016Phyllis S AndersonVPSell614$71.14$43,679.96View SEC Filing  
2/29/2016Everett NevilleVPSell4,323$71.00$306,933.00View SEC Filing  
6/9/2015Gary WimberlyVPSell1,644$87.14$143,258.16View SEC Filing  
6/1/2015Gary WimberlyVPSell46,069$86.15$3,968,844.35View SEC Filing  
3/2/2015Glen D StettinVPSell2,674$84.39$225,658.86View SEC Filing  
2/25/2015Glen D StettinVPSell27,603$87.55$2,416,642.65View SEC Filing  
12/2/2014Keith J EblingVPSell10,000$84.25$842,500.00View SEC Filing  
12/1/2014Steven B MillerVPSell4,896$83.57$409,158.72View SEC Filing  
11/28/2014Glen D StettinVPSell10,800$82.96$895,968.00View SEC Filing  
11/17/2014John O ParkerDirectorSell25,822$78.75$2,033,482.50View SEC Filing  
11/7/2014Maura C BreenDirectorSell13,128$77.80$1,021,358.40View SEC Filing  
9/5/2014Edward B IgnaczakEVPSell9,886$75.28$744,218.08View SEC Filing  
8/28/2014Seymour SternbergDirectorSell15,508$74.12$1,149,452.96View SEC Filing  
8/25/2014Keith J EblingVPSell10,000$75.50$755,000.00View SEC Filing  
8/5/2014Gary G BenanavDirectorSell12,694$70.82$898,989.08View SEC Filing  
8/5/2014Sara E WadeVPSell20,000$70.44$1,408,800.00View SEC Filing  
8/4/2014David A NortonVPSell1,276$71.02$90,621.52View SEC Filing  
8/1/2014Maura C BreenDirectorSell12,694$69.94$887,818.36View SEC Filing  
6/13/2014George PazCEOSell681,508$71.21$48,530,184.68View SEC Filing  
3/11/2014Keith EblingVPSell25,721$78.69$2,023,985.49View SEC Filing  
3/10/2014Patrick McnameeCOOSell68,425$78.28$5,356,309.00View SEC Filing  
3/10/2014Steven MillerVPSell12,664$77.96$987,285.44View SEC Filing  
3/7/2014Keith EblingVPSell295,367$77.29$22,828,915.43View SEC Filing  
1/9/2014Nicholas LahowchicDirectorSell7,650$72.00$550,800.00View SEC Filing  
12/26/2013Nicholas LahowchicDirectorSell12,694$70.00$888,580.00View SEC Filing  
11/5/2013Mahon Thomas MacDirectorSell10,251$63.20$647,863.20View SEC Filing  
9/9/2013Maura C BreenDirectorSell10,527$64.12$674,991.24View SEC Filing  
9/4/2013Woodrow Myers, Jr.DirectorSell7,128$64.66$460,896.48View SEC Filing  
7/19/2013Nicholas LahowchicDirectorSell20,377$66.26$1,350,180.02View SEC Filing  
6/11/2013Woodrow A Myers JrDirectorSell1,750$62.57$109,497.50View SEC Filing  
5/28/2013Woodrow A Myers JrDirectorSell2,000$63.75$127,500.00View SEC Filing  
5/15/2013Jeffrey HallCFOSell13,307$61.13$813,456.91View SEC Filing  
5/8/2013Woodrow A Myers JrDirectorSell13,462$61.22$824,143.64View SEC Filing  
5/1/2013Keith J EblingEVPSell59,494$59.58$3,544,652.52View SEC Filing  
4/30/2013Patrick McnameeCOOSell271,972$59.65$16,223,129.80View SEC Filing  
3/14/2013Mahon Thomas P MacDirectorBuy5,000$59.58$297,900.00View SEC Filing  
9/4/2012Jeffrey HallCFOSell75,000$62.81$4,710,750.00View SEC Filing  
8/8/2012Edward B IgnaczakEVPSell115,466$59.33$6,850,597.78View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Express Scripts Holding Company (NASDAQ:ESRX)
DateHeadline
finance.yahoo.com logoEXPRESS SCRIPTS HOLDING CO. Financials (NASDAQ:ESRX)
finance.yahoo.com - February 18 at 4:44 PM
News IconExpress Scripts Holding Company (NASDAQ:ESRX) To Release Earnings (NASDAQ:ESRX)
cloudhostinghq.net - February 17 at 5:28 PM
capitalcube.com logoExpress Scripts Holding Co. :ESRX-US: Earnings Analysis: Q4, 2016 By the Numbers : February 17, 2017 (NASDAQ:ESRX)
www.capitalcube.com - February 17 at 5:28 PM
finance.yahoo.com logoThe Zacks Analyst Blog Highlights: Merck, PNC Financial, Express Scripts, VeriSign and Martin Marietta (NASDAQ:ESRX)
finance.yahoo.com - February 17 at 5:28 PM
marketexclusive.com logoEXPRESS SCRIPTS HOLDING COMPANY (NASDAQ:ESRX) Files An 8-K Results of Operations and Financial Condition (NASDAQ:ESRX)
marketexclusive.com - February 16 at 4:49 PM
News IconStock to watch: Express Scripts Holding Company (NASDAQ: ESRX) (NASDAQ:ESRX)
fxdailyreport.com - February 16 at 4:49 PM
seekingalpha.com logoExpress Scripts Holding (ESRX) Q4 2016 Results - Earnings Call Transcript (NASDAQ:ESRX)
seekingalpha.com - February 16 at 4:49 PM
News IconExpress Scripts Holding Company (ESRX) Releases FY17 Earnings Guidance (NASDAQ:ESRX)
techknowbits.com - February 16 at 4:49 PM
biz.yahoo.com logoExpress Scripts Holding Co Earnings Call scheduled for 8:30 am ET today (NASDAQ:ESRX)
us.rd.yahoo.com - February 16 at 4:49 PM
thestreet.com logoExpress Scripts Officials Use Earnings Call to Blame Pharma for Drug Pricing (NASDAQ:ESRX)
us.rd.yahoo.com - February 16 at 4:49 PM
thestreet.com logoExpress Scripts: Rx For Earnings Growth (NASDAQ:ESRX)
us.rd.yahoo.com - February 16 at 4:49 PM
us.rd.yahoo.com logoEdited Transcript of ESRX earnings conference call or presentation 15-Feb-17 1:30pm GMT (NASDAQ:ESRX)
us.rd.yahoo.com - February 16 at 4:49 PM
finance.yahoo.com logoCompany News for February 16, 2017 (NASDAQ:ESRX)
finance.yahoo.com - February 16 at 4:49 PM
finance.yahoo.com logoWe dug into the drug company Martin Shkreli sold out to the feds, and man is it ugly (NASDAQ:ESRX)
finance.yahoo.com - February 16 at 4:49 PM
finance.yahoo.com logoQ4 Earnings Season Scorecard & Top Analyst Reports (NASDAQ:ESRX)
finance.yahoo.com - February 16 at 4:49 PM
finance.yahoo.com logoExpress Scripts Named one of Fortune Magazine's World's Most Admired Companies of 2017 (NASDAQ:ESRX)
finance.yahoo.com - February 16 at 4:49 PM
News IconPeeling Back The Layers on Express Scripts Holding Company (NASDAQ:ESRX): Analysts & Street Weigh In - Winfield Review (NASDAQ:ESRX)
winfieldreview.com - February 15 at 4:06 AM
nasdaq.com logoExpress Scripts Holding Company Reveals 8% Rise In Q4 Earnings - Nasdaq (NASDAQ:ESRX)
www.nasdaq.com - February 15 at 4:06 AM
finanznachrichten.de logoEXPRESS SCRIPTS HOLDING COMPANY (NASDAQ:ESRX)
www.finanznachrichten.de - February 14 at 11:06 PM
thestreet.com logoExpress Scripts Posts $5.39 Per Diluted Share Ahead of Feb. 15 Earnings Call (NASDAQ:ESRX)
www.thestreet.com - February 14 at 11:06 PM
rttnews.com logoExpress Scripts Holding Company Reveals 8% Rise In Q4 Earnings (NASDAQ:ESRX)
www.rttnews.com - February 14 at 6:03 PM
News IconExpress Scripts Holding Company (ESRX): Immense Growth Potential? (NASDAQ:ESRX)
simplywall.st - February 14 at 6:03 PM
biz.yahoo.com logoQ4 2016 Express Scripts Holding Co Earnings Release - After Market Close (NASDAQ:ESRX)
us.rd.yahoo.com - February 14 at 6:03 PM
us.rd.yahoo.com logoExpress Scripts Announces 2016 Fourth Quarter and Full Year Results (NASDAQ:ESRX)
us.rd.yahoo.com - February 14 at 6:03 PM
us.rd.yahoo.com logoExpress Scripts EPS beats, revenues miss (NASDAQ:ESRX)
us.rd.yahoo.com - February 14 at 6:03 PM
us.rd.yahoo.com logo4:04 pm Express Scripts beats by $0.01, misses on revs; guides Q1 EPS below consensus; reaffirms FY17 EPS guidance (NASDAQ:ESRX)
us.rd.yahoo.com - February 14 at 6:03 PM
biz.yahoo.com logoEXPRESS SCRIPTS HOLDING CO. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:ESRX)
us.rd.yahoo.com - February 14 at 6:03 PM
sg.finance.yahoo.com logoExpress Scripts beats 4Q profit forecasts (NASDAQ:ESRX)
sg.finance.yahoo.com - February 14 at 6:03 PM
wsj.com logo[$$] Express Scripts Revenue Falls (NASDAQ:ESRX)
www.wsj.com - February 14 at 6:03 PM
News IconTaking a Look at the Chart for Express Scripts Holding Company (ESRX) - The USA Commerce (NASDAQ:ESRX)
theusacommerce.com - February 14 at 4:00 AM
News IconIs Express Scripts Holding Company (ESRX) Preparing For A Breakout Trade? (NASDAQ:ESRX)
ibusinesslines.com - February 11 at 5:07 PM
News IconShort Interest in Express Scripts Holding Company (ESRX) Increases By 23.9% (NASDAQ:ESRX)
latribunadecanarias.com - February 11 at 5:07 PM
News IconExpress Scripts Holding Company's (ESRX) (NASDAQ:ESRX)
techknowbits.com - February 11 at 5:07 PM
News IconLeading stocks in today’s market: Express Scripts Holding Company (NASDAQ:ESRX) (NASDAQ:ESRX)
twincountynews.com - February 10 at 10:36 PM
News IconNotable Stock Analysts Ratings: Express Scripts Holding Company (NASDAQ:ESRX) (NASDAQ:ESRX)
mlbinjurynews.com - February 10 at 5:34 PM
News IconExpress Scripts Holding Company (NASDAQ:ESRX) Analyst Estimates (NASDAQ:ESRX)
cote-ivoire.com - February 9 at 10:39 PM
News IconExpress Scripts Holding Company (NASDAQ:ESRX) Met Earnings 5 times (NASDAQ:ESRX)
xboxonezone.com - February 9 at 10:39 PM
News IconLookout for Price Target? ONEOK, Inc. (OKE), Express Scripts Holding Company (ESRX) - StockNewsJournal (NASDAQ:ESRX)
stocknewsjournal.com - February 9 at 5:37 PM
News IconCompany Stock in Focus: Express Scripts Holding Company (NASDAQ:ESRX) - Rives Journal (NASDAQ:ESRX)
rivesjournal.com - February 8 at 10:36 PM
nasdaq.com logoExpress Scripts (ESRX) Q4 Earnings: What's in the Cards? - Nasdaq (NASDAQ:ESRX)
www.nasdaq.com - February 8 at 10:36 PM
finance.yahoo.com logoExpress Scripts (ESRX) Q4 Earnings: What's in the Cards? (NASDAQ:ESRX)
finance.yahoo.com - February 8 at 5:34 PM
News IconBest stocks of the day: Express Scripts Holding Company (NASDAQ:ESRX) (NASDAQ:ESRX)
hoyentv.com - February 8 at 4:17 AM
News IconFocusing on the Charts for Express Scripts Holding Company (ESRX) - Davidson Register (NASDAQ:ESRX)
davidsonregister.com - February 7 at 11:16 PM
News IconMomentum Watch on Shares of Express Scripts Holding Company (NASDAQ:ESRX) - Providence Standard (NASDAQ:ESRX)
providencestandard.com - February 7 at 11:16 PM
News IconHealth Care Plans: Express Scripts Holding Company (NASDAQ:ESRX) Position of the day (NASDAQ:ESRX)
twincountynews.com - February 7 at 6:16 PM
bizjournals.com logoAffordable Obamacare alternative possible, Express Scripts CEO says (NASDAQ:ESRX)
www.bizjournals.com - February 7 at 6:15 PM
realistinvestor.com logoExpress Scripts Holding Company (NASDAQ:ESRX) Accounts Payable Is $3791.1 For ... (NASDAQ:ESRX)
www.realistinvestor.com - February 6 at 10:09 PM
investopedia.com logoExpress Script: Prescription Drug Spending Slowed (ESRX) (NASDAQ:ESRX)
www.investopedia.com - February 6 at 5:07 PM
News IconTop Gainers of the Day: Express Scripts Holding Company (NASDAQ:ESRX) from Health Care Plans (NASDAQ:ESRX)
twincountynews.com - February 6 at 5:07 PM
finance.yahoo.com logoOne of the largest middlemen in the pharma industry just shed a little light on the murky world of drug pricing (NASDAQ:ESRX)
finance.yahoo.com - February 6 at 5:07 PM

Social

What is Express Scripts Holding Company's stock symbol?

Express Scripts Holding Company trades on the NASDAQ under the ticker symbol "ESRX."

Where is Express Scripts Holding Company's stock going? Where will Express Scripts Holding Company's stock price be in 2017?

16 brokers have issued 1 year target prices for Express Scripts Holding Company's shares. Their forecasts range from $59.00 to $88.00. On average, they expect Express Scripts Holding Company's stock price to reach $77.08 in the next twelve months.

When will Express Scripts Holding Company announce their earnings?

Express Scripts Holding Company is scheduled to release their next quarterly earnings announcement on Monday, April, 24th 2017.

What are analysts saying about Express Scripts Holding Company stock?

Here are some recent quotes from research analysts about Express Scripts Holding Company stock:

  • Jefferies Group LLC analysts commented, "We believe ESRX remains a Buy given our view that company fundamentals, including its FCF, are stable and that the stock's valuation is attractive at 9x FY18 P/E. That said, we recognize that headlines surrounding drug pricing pressure and the overhang from ESRX's Anthem contract will drive continued stock volatility NT." (2/17/2017)
  • According to Zacks Investment Research, "Express Scripts’ fourth-quarter 2016 results were mixed, wherein adjusted earnings topped the Zacks Consensus Estimate, revenues beat the same. In the past three months, the company has underperformed the broader industry with respect to price performance. While the company’s guidance for 2017 was encouraging, tough competition in the Pharmacy Benefit Management space and the persistent drug pricing issue are expected to affect the share price. Express Scripts stands to benefit from increased generic utilization, shift toward mail orders, strong specialty growth and an aging population. The company is focused on the development of both specialty drugs and generics, which are expected to account for 50% of the total drug expenditure by 2018. Further, its SafeGuardRx suite of products is designed to better manage specialty spend in turn, establishing a higher standard for patient outcomes." (2/16/2017)

  • Credit Suisse Group analysts commented, "We continue to believe ESRX will seek to buy Rite Aid’s PBM unit from Walgreens if the deal closes successfully and possibly add its generic purchasing clout to Walgreen’s buying consortium for added economics. Derivatives: At a time when hapless politicians are wringing their wrists about out of control drug costs, we cite another example of a large government payor tapping PBM solutions for greater savings. As opposed to Anthem, TRICARE utilizes a number of ESRX’s cost management tools in addition to a preferred pharmacy network to better manage its trend. We see the PBM model as more rather than less relevant to the current situation, and we see longer-term enhanced roles for PBMs in Medicare part D and B. Separately, we see AmerisourceBergen as benefiting from the news as Walgreen’s supplier, while Cardinal Health stand to lose some share as CVS’s partner." (10/3/2016)

Who owns Express Scripts Holding Company stock?

Express Scripts Holding Company's stock is owned by many different of retail and institutional investors. Top institutional investors include State Street Corp (4.34%), Barrow Hanley Mewhinney & Strauss LLC (2.74%), Dimensional Fund Advisors LP (1.01%), Cedar Rock Capital Ltd. (0.83%), Chieftain Capital Management Inc. (0.79%) and Davis Selected Advisers (0.70%). Company insiders that own Express Scripts Holding Company stock include Christopher A Mcginnis, Everett Neville, Gary Wimberly, Glen D Stettin, Mahon Thomas P Mac, Phyllis S Anderson and Woodrow A Myers Jr.

Who sold Express Scripts Holding Company stock? Who is selling Express Scripts Holding Company stock?

Express Scripts Holding Company's stock was sold by a variety of institutional investors in the last quarter, including FIL Ltd, FMR LLC, Thornburg Investment Management Inc., Barrow Hanley Mewhinney & Strauss LLC, Davis Selected Advisers, Brown Advisory Inc., AQR Capital Management LLC and Teachers Retirement System of The State of Kentucky. Company insiders that have sold Express Scripts Holding Company stock in the last year include Christopher A Mcginnis, Everett Neville, Mahon Thomas P Mac, Phyllis S Anderson and Woodrow A Myers Jr.

Who bought Express Scripts Holding Company stock? Who is buying Express Scripts Holding Company stock?

Express Scripts Holding Company's stock was bought by a variety of institutional investors in the last quarter, including Brave Warrior Advisors LLC, Russell Investments Group Ltd., Elkfork Partners LLC, Asset Management One Co. Ltd., Tyers Asset Management LLC, Chieftain Capital Management Inc., Equity Investment Corp Acquisition Inc and DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main.

How do I buy Express Scripts Holding Company stock?

Shares of Express Scripts Holding Company can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Express Scripts Holding Company stock cost?

One share of Express Scripts Holding Company stock can currently be purchased for approximately $69.97.

Express Scripts Holding Company (NASDAQ:ESRX) Chart for Monday, February, 20, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Express Scripts Holding Company (NASDAQ:ESRX)

Earnings History Chart

Earnings by Quarter for Express Scripts Holding Company (NASDAQ:ESRX)

Dividend History Chart

Dividend Payments by Quarter for Express Scripts Holding Company (NASDAQ:ESRX)

Last Updated on 2/20/2017 by MarketBeat.com Staff